Thomas Moehler - Publications, H-index & Citations

Thomas Moehler

Ruprecht Karls University Heidelberg

31H指数

98论文数

2.9K被引数

收录论文 19

发表时间

Usage Pattern of CAR-T and CD3xCD20 T-Cell-Engaging Bi-Specific Monoclonal Antibodies in B-NHL Patients in EU4+UK CAR-T和CD3xCD20 T细胞结合双特异性单克隆抗体在EU4+UK地区B-NHL患者中的使用模式

BLOOD

IF23.1

2024-11-05

PREAI

Ruiz, Magdalena; Perez, Angela; Alonso, Isabel; Anger, Caroline; Moehler, Thomas; Solari, Maria Leticia; Cuns, Daniela Ivanna; Ferrerosa, Lauren; French, James A.; Jindal, Kriti

Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4+UK perspective

FUTURE ONCOLOGY

IF2.6

2023-11-17

OAAI

Ruiz, Magdalena; Jindal, Kriti; Casey, Vicky; Soares, Luana Margotto; Manuguid, Fil; Moehler, Thomas

Progression -free survival prediction of multiple myeloma patients in five European countries using machine learning models

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Witte, M. L. Pleguezuelo; Muller, M.; Hartmann, J.; Ricarte, C.; Moehler, T.; Lopez, M.; Jindal, K.

The CDK4/6 inhibitors takeover of the HR+/HER2-locally advanced to metastatic breast cancer market in the EU5: Findings from a real-world study

ANNALS OF ONCOLOGY

IF65.4

2021-09-01

OAAI

Graff, P-O.; Jindal, K.; Anger, C.; Mendoza, L. A.; Moehler, T.

Adoption of immune checkpoint inhibitors (ICIs) in bladder cancer: Findings from a real-world study in EU5

ANNALS OF ONCOLOGY

IF65.4

2020-09-01

OAAI

Jindal, K.; Mendoza, L.; Moehler, T.; Anger, C.

Sorafenib in patients with refractory or recurrent multiple myeloma 索拉非尼治疗难治性或复发性多发性骨髓瘤

HEMATOLOGICAL ONCOLOGY

IF3.9

2013-03-15

PREAI

Yordanova, Anna; Hose, Dirk; Neben, Kai; Witzens-Harig, Mathias; Guetgemann, Ines; Raab, Marc-Steffen; Moehler, Thomas; Goldschmidt, Hartmut; Schmidt-Wolf, Ingo G. H.

Analysis of recruitment of non small cell lung cancer patients into clinical trials

CANCER RESEARCH

IF16.6

2012-04-01

PREAI

Joubert, Richard; Bortini, Stefanella; Raeth, Ulrich; Moehler, Thomas

Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling

ANGIOGENESIS

IF9.2

2010-02-17

PREAI

Willhauck-Fleckenstein, Martina; Moehler, Thomas M.; Merling, Anette; Pusunc, Susann; Goldschmidt, Hartmut; Schwartz-Albiez, Reinhard

Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging

RADIOLOGY

IF15.2

2009-08-01

PREAI

Baeuerle, Tobias; Hillengass, Jens; Fechtner, Kerstin; Zechmann, Christian M.; Grenacher, Lars; Moehler, Thomas M.; Heiss, Christiane; Wagner-Gund, Barbara; Neben, Kai; Kauczor, Hans-Ulrich; Goldschmidt, Hartmut; Delorme, Stefan

Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone

ANNALS OF HEMATOLOGY

IF2.4

2008-07-31

OAAI

Klein, Ulrike; Kosely, Florentina; Hillengass, Jens; Hundemer, Michael; Schmitt, Stefan; Neben, Kai; Moehler, Thomas; Hegenbart, Ute; Ho, Anthony D.; Goldschmidt, Hartmut

Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2008-04-09

PREAI

Hillengass, Jens; Zechmann, Christian M.; Nadler, Andreas; Hose, Dirk; Cremer, Friedrich W.; Jauch, Anna; Heiss, Christiane; Benner, Axel; Ho, Anthony D.; Bartram, Claus R.; Kauczor, Hans-Ulrich; Delorme, Stefan; Goldschmidt, Hartmut; Moehler, Thomas M.

Where is the primary tumour?

LANCET

IF88.5

2007-11-01

PREAI

Zechmann, Christian M.; Giesel, Frederik L.; Hillengass, Jens; Mehndiratta, Amit; Neben, Kai; Delorme, Stefan; Moehler, Thomas

Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation

ANNALS OF HEMATOLOGY

IF2.4

2007-06-29

PREAI

Witzens-Harig, Mathias; Waldherr, Ruediger; Beimler, Joerg; Zeier, Martin; Hansmann, Jochen; Ho, Anthony D.; Goldschmidt, Hartmut; Moehler, Thomas